Dec 13, 2017 · Irish pharma giant Allergan plc AGN has recently inked a definitive agreement to acquire a Texas-based development stage biopharmaceutical company, Repros Therapeutics RPRX.Repros is focused on developing new drugs to treat hormonal and reproductive system disorders. Shares of Allergan have declined 18.2% this year so far, comparing favorably with the industry 's decrease of 28.1%. AGN Stock Price & Charts | Allergan In depth view into AGN (Allergan) stock including the latest price, news, dividend history, earnings information and financials. AGN Stock Price, Forecast & News (Allergan) | MarketBeat
Allergan plc Stock Quote: AGN Stock News, Quotes, Analysis ...
View today's stock price, news and analysis for Allergan PLC (AGN). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Analysts Conflicted on These Healthcare Names: Galapagos ... The word on The Street in general, suggests a Hold analyst consensus rating for Allergan with a $200.75 average price target, implying a 1.6% upside from current levels. In a report issued on February 11, Stifel Nicolaus also maintained a Hold rating on the stock with a … Allergan Stock Falls as FDA OK's Botox Rival for Frown ... Allergan's (AGN) stock declines almost 4% after FDA approves Evolus' Jeuveau injection to treat frown lines, which can pose strong competition to Botox.
Jun 25, 2019 · According to a statement from AbbVie, the offer is worth about $188 a share in cash and stock, which represents a 45% premium from Allergan's …
Allergan plc. (AGN) Dividend Date & History - Nasdaq 23 rows · See the upcoming ex dividend date and dividend history for Allergan plc. (AGN). Stay alerted … AGN Stock Price | Allergan PLC Stock Quote (U.S.: NYSE ... Allergan's stock rises as adjusted profit, revenue beat expectations Shares of Allergan PLC rose 1% in premarket trading Monday, after the drug maker reported a fourth-quarter adjusted profit and
Records 1 - 18 of 21 Find the latest historical data for Allergan plc Ordinary
15 analysts have issued 12 month price objectives for Allergan's shares. Their forecasts range from $144.95 to $203.00. On average, they anticipate Allergan's share price to reach $180.08 in the next year. This suggests a possible upside of 2.5% from the stock's current price. … Allergan PLC (AGN) Quote | Morningstar Mar 27, 2020 · Learn about AGN with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to …
AGN: Allergan plc - Stock Price, Quote and News - CNBC
View today's stock price, news and analysis for Allergan PLC (AGN). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Analysts Conflicted on These Healthcare Names: Galapagos ... The word on The Street in general, suggests a Hold analyst consensus rating for Allergan with a $200.75 average price target, implying a 1.6% upside from current levels. In a report issued on February 11, Stifel Nicolaus also maintained a Hold rating on the stock with a … Allergan Stock Falls as FDA OK's Botox Rival for Frown ... Allergan's (AGN) stock declines almost 4% after FDA approves Evolus' Jeuveau injection to treat frown lines, which can pose strong competition to Botox. Allergan plc Stock Becomes a Buy as It Bottoms Out ... May 01, 2018 · Allergan stock slumped in trading after the earnings announcement. A big write-down is hammering the stock price, but that could make it a buy. Nasdaq quotes delayed at least 15 minutes, all